Rafferty Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,856
Closed -$161K 1314
2021
Q4
$161K Sell
11,856
-2,096
-15% -$29.7K ﹤0.01% 1240
2021
Q3
$205K Sell
13,952
-2,909
-17% -$49.1K ﹤0.01% 1189
2021
Q2
$307K Buy
16,861
+5,965
+55% +$106K ﹤0.01% 1173
2021
Q1
$189K Buy
+10,896
New +$192K ﹤0.01% 1150
2020
Q4
Sell
-13,548
Closed -$187K 1046
2020
Q3
$187K Buy
+13,548
New +$199K ﹤0.01% 922

Other funds holding SBRA

Rafferty Asset Management's SBRA Position: Q1 2022 in Review

Rafferty Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q1 2022, closing a stake of 11,856 shares — an estimated $161K sold.

Rafferty Asset Management first reported a position in SBRA in Q3 2020 and held it in 5 quarters. The position peaked at $307K in Q2 2021. 326 funds tracked by Wall St. Rank hold SBRA as of Q1 2022.

  • Rafferty Asset Management reported no remaining Sabra Healthcare REIT position as of Q1 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 11,856 Sabra Healthcare REIT shares in Q1 2022, an estimated $161K.
  • Rafferty Asset Management first reported a position in Sabra Healthcare REIT in Q3 2020 and held it in 5 quarters.
  • Rafferty Asset Management's Sabra Healthcare REIT position peaked at $307K in Q2 2021.
  • 326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2022.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.